State of Tennessee, Department of Treasury
CNTA

State of Tennessee, Department of Treasury’s Centessa Pharmaceuticals CNTA Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,798
Closed -$65.5K – 1724
2024
Q1 		$65.5K Buy
+5,798
New +$54.9K ﹤0.01% 1668

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State of Tennessee, Department of Treasury's CNTA Position: Q2 2024 in Review

State of Tennessee, Department of Treasury sold out of Centessa Pharmaceuticals (CNTA) in Q2 2024, closing a stake of 5,798 shares — an estimated $65.5K sold.

State of Tennessee, Department of Treasury first reported a position in CNTA in Q1 2024 and held it in 1 quarter. The position peaked at $65.5K in Q1 2024. 80 funds tracked by Wall St. Rank hold CNTA as of Q2 2024.

  • State of Tennessee, Department of Treasury reported no remaining Centessa Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 5,798 Centessa Pharmaceuticals shares in Q2 2024, an estimated $65.5K.
  • State of Tennessee, Department of Treasury first reported a position in Centessa Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • State of Tennessee, Department of Treasury's Centessa Pharmaceuticals position peaked at $65.5K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2024.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2024, filed 13 Aug 2024.